Back
Eliem Therapeutics 10K Form
Sell
45
ELYM
Eliem Therapeutics
Last Price:
8.25
Seasonality Move:
-25.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ELYM News And Ratings
See the #1 stock for the next 7 days that we like better than ELYM
ELYM Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.82M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.84 |
| Price / Book: | 2.26 |
Profitability
| EPS (TTM): | -0.53000 |
|---|---|
| Net Income (TTM): | $-14.53M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Eliem Therapeutics Earnings Forecast
Key Eliem Therapeutics Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 2 years.
Eliem Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ELYM |
| Website: | eliemtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ELYM Technical Analysis vs Fundamental Analysis
Sell
45
Eliem Therapeutics (ELYM)
is a Sell
Is Eliem Therapeutics a Buy or a Sell?
-
Eliem Therapeutics stock is rated a Sell
The current Eliem Therapeutics [ELYM] share price is $8.25. The Score for ELYM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.